%0 Journal Article
%T Standardized classification schemes in reporting oncologic PET/CT.
%A Murad V
%A Kulanthaivelu R
%A Ortega C
%A Veit-Haibach P
%A Metser U
%J Front Med (Lausanne)
%V 9
%N 0
%D 2022
%M 36777163
%F 5.058
%R 10.3389/fmed.2022.1051309
%X The imaging report is essential for the communication between physicians in patient care. The information it contains must be clear, concise with evidence-based conclusions and sufficient to support clinical decision-making. In recent years, several classification schemes and/or reporting guidelines for PET have been introduced. In this manuscript, we will review the classifications most frequently used in oncology for interpreting and reporting 18F-FDG PET imaging in lymphoma, multiple myeloma, melanoma and head and neck cancers, PSMA-ligand PET imaging for prostate cancer, and 68Ga-DOTA-peptide PET in neuroendocrine tumors (NET).